Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Keloids, hypertrophic scars, and burn hypertrophic scars are all forms of proliferative scarring characterized by overabundant matrix formation. Recently these dermal proliferative disorders have been linked clinically to the cytokine transforming growth factor beta (TGF-beta), and in vitro tests have shown it to be responsible for the activation of fibroblasts and their production and deposition of collagen. Using an established in vivo animal model of proliferative scarring, the effects of this cytokine, specifically the isoform TGF-beta2, on these scars were examined. Proliferative scar specimens were implanted into athymic, asplenic nude rats and isolated in sandwich island flaps based on the superficial inferior epigastric pedicle. After establishment of the transferred flap, the scars were injected with varying doses of TGF-beta2 or vehicle for 5 consecutive days and then again on days 10, 15, and 20. The specimens were measured weekly during the period of dosing, and a biopsy was acquired on days 30 and 60. Fibroblasts from the explanted biopsies and the original scars were grown in cell culture, and cell proliferation studies were performed and the results compared. There was a dose response to TGF-beta2, with 200 ng showing the greatest effect. From the original scar specimens, keloid scars demonstrated the greatest cell proliferation kinetics--significantly faster than nonburn and burn hypertrophic scars. After treatment with TGF-beta2, both keloids and burn hypertrophic scars showed an increase in their cell proliferation kinetics compared with vehicle alone. This was not demonstrated with the nonburn hypertrophic scars. Elevated levels of TGF-beta2 are a major contributing factor to the process of proliferative scars, but because nonburn hypertrophic scars do not result in an equally increased response to this cytokine, a truly causative role for this cytokine cannot be promulgated. Rather, it is the combination of the proliferative scar fibroblasts' abnormal response to TGF-beta2 stimulation and elevated levels of this cytokine that controls more accurately the process of keloid and burn hypertrophic scar formation.
Polo
M
M
Institute for Tissue Regeneration, Repair and Rehabilitation, Bay Pines VA Medical Center, FL 33744, USA.
Smith
P D
PD
Kim
Y J
YJ
Wang
X
X
Ko
F
F
Robson
M C
MC
D000818:Animals; D002455:Cell Division; D002478:Cells, Cultured; D017439:Cicatrix, Hypertrophic / Q000473:pathology*; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D007627:Keloid / Q000473:pathology*; D020033:Protein Isoforms / Q000494:pharmacology; D051381:Rats; D011923:Rats, Nude; D013524:Surgical Flaps; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
D020033:Protein Isoforms; D016212:Transforming Growth Factor beta